Pharmaceutical - USA

Filter

Current filters:

USA

Popular Filters

1 to 25 of 881 results

UPDATE: Novo Nordisk rises as it says it plans to resubmit Tresiba and Ryzodeg NDAs in USA

UPDATE: Novo Nordisk rises as it says it plans to resubmit Tresiba and Ryzodeg NDAs in USA

27-03-2015

Danish diabetes care giant Novo Nordisk has decided to submit the pre-specified interim analysis of DEVOTE…

DiabetesNovo NordiskPharmaceuticalRegulationResearchRyzodegTresibaUSA

Shire and Cincinnati Children's Hospital collaborate on rare disease research

Shire and Cincinnati Children's Hospital collaborate on rare disease research

26-03-2015

Ireland-headquartered drugmaker Shire has entered into a three-year broad research collaboration for…

PharmaceuticalRare diseasesResearchShireUSA

Sanofi Pasteur’s Quadracel vaccine gets FDA approval

26-03-2015

French pharma major Sanofi’s (Euronext: SAN) Sanofi Pasteur has received approval from the US Food…

PharmaceuticalQuadracelRegulationSanofiSanofi PasteurUSAVaccines

FDA approval for Emergent BioSolutions’ Anthrasil

25-03-2015

US biopharma company Emergent BioSolutions has received approval from the US Food and Drug Administration…

AnthrasilAntibiotics and Infectious diseasesEmergent BioSolutionsPharmaceuticalRegulationUSA

USA’s HHS seeks to develop improved anthrax vaccine

24-03-2015

Advanced development is underway on an improved anthrax vaccine that could provide protection in fewer…

BioThraxEmergent BioSolutionsFinancialNuThraxPharmaceuticalResearchUSAVaccines

FDA safety review of Zyprexa Relprevv calls for no changes to current prescribing

24-03-2015

The US Food and Drug Administration has concluded a review of a study undertaken to determine the cause…

Eli LillyHealthcareNeurologicalPharmaceuticalRegulationUSAZyprexa Relprevv

Pfizer and Lilly gear up to resume Phase III chronic pain program for tanezumab

23-03-2015

US pharma majors Pfizer and Eli Lilly both saw their shares rise in pre-market trading today, as they…

Eli LillyLicensingNeurologicalPfizerPharmaceuticalRegulationUSA

Costs and consequences of not treating high cholesterol in the USA

23-03-2015

High cholesterol itself is not a disease, but it can lead to serious health consequences, according to…

Cardio-vascularFinancialHealthcarePharmaceuticalUSA

Survey of hydrocodone patients shows schedule changes negatively impact treatment

Survey of hydrocodone patients shows schedule changes negatively impact treatment

20-03-2015

A survey of pain patients to assess the effects of rescheduling hydrocodone has shown that it negatively…

AnalgesiahydrocodoneMarkets & MarketingPharmaceuticalPricingSocial IssuesUSA

Dilaforette's sevuparin granted orphan drug designation by FDA in sickle-cell disease

Dilaforette's sevuparin granted orphan drug designation by FDA in sickle-cell disease

20-03-2015

Dilaforette, a portfolio company of Karolinska Development, a Nordic investor in life sciences, has been…

DilaforetteHematologyPharmaceuticalRegulationResearchSevuparinSwedenUSA

AstraZeneca to co-commercialize Movantik with Daiichi Sankyo in USA

AstraZeneca to co-commercialize Movantik with Daiichi Sankyo in USA

19-03-2015

Anglo-Swedish pharma major AstraZeneca has inked a deal with Japanese peer Daiichi Sankyo for the co-commercialization…

AstraZenecaDaiichi SankyoGastro-intestinalsMarkets & MarketingMovantikPharmaceuticalUSA

Inovio appoints Scott White as vice president of clinical development in infectious diseases

Inovio appoints Scott White as vice president of clinical development in infectious diseases

18-03-2015

USA-based pharma company Inovio Pharmaceuticals has appointed Scott White as vice president of clinical…

BoardroomInovio PharmaceuticalsPharmaceuticalUSA

USA rapidly losing bioscience research market share to Asia

USA rapidly losing bioscience research market share to Asia

18-03-2015

The latest data from antibody search engine CiteAb suggests that the USA has continued to lose its share…

ChinaIndiaPharmaceuticalResearchUSA

US market for asthma drugs set to reach $14 billion by 2020

US market for asthma drugs set to reach $14 billion by 2020

18-03-2015

The US treatment market for asthma will rise in value from $11.7 billion in 2013 to an estimated $14…

Arnuity ElliptaFloventGlaxoSmithKlineMarkets & MarketingPharmaceuticalRelvarRespiratory and PulmonaryUSA

Actavis' sNDA for Saphris approved by FDA

Actavis' sNDA for Saphris approved by FDA

16-03-2015

The US Food and Drug Administration has approved the supplemental New Drug Application for Saphris (asenapine),…

ActavisNeurologicalPharmaceuticalRegulationSaphrisUSA

FDA again delays decision on Merck’s investigational drug sugammadex

14-03-2015

The US Food and Drug Administration has cancelled the meeting of the Anesthetic and Analgesic Drug Products…

Merck & CoNeurologicalPharmaceuticalRegulationsugammadexUSA

Most clinical trial results not reported within ClinicalTrials.gov guidelines

Most clinical trial results not reported within ClinicalTrials.gov guidelines

13-03-2015

Although pharma companies are required to report clinical trial results to ClinicalTrials.gov in a timely…

MedicineNew England JournalPharmaceuticalResearchUSA

Ocular Therapeutix reports positive top-line data from Phase III OTX-DP trial

Ocular Therapeutix reports positive top-line data from Phase III OTX-DP trial

11-03-2015

Biopharma company Ocular Therapeutix has announced positive top-line data from the first of two Phase…

Ocular TherapeutixOphthalmicsPharmaceuticalResearchUSA

Pershing takes nearly 5% of Valeant shares worth $3.3 billion

Pershing takes nearly 5% of Valeant shares worth $3.3 billion

10-03-2015

Capital management firm Pershing Square Holdings has announced a new position in acquisitive Canadian…

FinancialPershing CapitalPharmaceuticalUSAValeant International

FDA updates label on Pfizer's Chantix to warn of interaction with alcohol

FDA updates label on Pfizer's Chantix to warn of interaction with alcohol

10-03-2015

The US Food and Drug Administration has updated the label on Chantix (varenicline), marketed by Pfizer,…

ChantixNeurologicalPfizerPharmaceuticalRegulationUSA

2014 saw highest increase in US drug spend over past decade

2014 saw highest increase in US drug spend over past decade

10-03-2015

In 2014, the pharmacy landscape underwent a seismic change, and the budgetary impact to healthcare payers…

Anti-viralsFinancialGilead SciencesHarvoniHealthcareJohnson & JohnsonMarkets & MarketingOlysioPharmaceuticalSovaldiUSA

Lycera appoints Jeffrey Wilkins as chief medical officer

09-03-2015

US oncology and autoimmune biopharma company Lycera has appointed Jeffrey Wilkins to the newly-created…

BoardroomBusiness FinanceJeffrey WilkinsLyceraOncologyPharmaceuticalUSAWilkins

1 to 25 of 881 results

Back to top